Tivozanib
Tivozanib, sold under the brand name Fotivda, is a medication used for the treatment of relapsed or refractory advanced renal cell carcinoma. It is an oral VEGF receptor tyrosine kinase inhibitor. Reference standards of Tivozanib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Tivozanib - API Standards
[catalogue_number] => PA 73 42000
[category_ids] => ,75,76,78,70,82,
[chemical_name] =>
[weight] => 454.86
[form] => C22H19ClN4O5
[cas] => 475108-18-0
[pslug] => 475108-18-0-tivozanib-api-pa7342000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Tivozanib - API Standards
Catalogue No.:PA 73 42000
Molecular Formula : C22H19ClN4O5
Molecular Weight : 454.86